Diane Elizabeth Sullivan is an accomplished commercial executive with extensive leadership experience and proven success in life sciences (AstraZeneca, Pfizer, GlaxoSmithKline), consumer healthcare (GlaxoSmithKline) and technology (IBM) at US and UK domiciled global corporations. She has a reputation as a strategic thinker who has led US and global functions with sales of $2 to $20B and who consistently grows businesses and builds high performing teams.
Diane’s expertise in customer-focused and patient-centered strategy setting and operational excellence enables delivery of new capabilities that differentiate a company’s portfolio and brands. She has led teams through turbulent times in sales, marketing, market access and business development inclusive of acquisition and licensing negotiations, due diligence and integration. Diane has launch and in-line experience from rare disease to blockbusters in most therapeutic areas. She is a highly regarded leader who inspires entrepreneurial thinking and behaviors that foster an environment where talent can do their best work.
Most recently, Diane was Vice President of Market Access and Patient Strategies at AstraZeneca and a member of the North America Leadership Team responsible for sales of $20B and 500+ customer relationships. Under her leadership of 360 colleagues, AZ’s ranking improved +4 with external customers, engagement scores improved +20 points and her teams were awarded 3 Presidents Awards and the 2016 CEO Award. A few notable accomplishments are:
- Successfully delivered 12+ launches while managing 10 multi-million dollar in-line brands and leading patent expiration strategies for NEXIUM®, CRESTOR®, SEROQUEL XR®, delivering net sales above industry analogues in the face of new competition and disruptive change.
- Pioneered development of an innovative approach to gaining access for patients to AZ brands, executing 12+ value-based agreements through a unique approach with three customer segments and three different therapeutic areas.
- Built strategic capabilities that have differentiated AZ brands and exceeded industry benchmarks including in-housing portfolio-wide reimbursement services, establishing a specialty distribution and dispensing ecosystem and implementing a cloud-based contract management system delivered $6M below budget and ahead of schedule while managing 1800 contracts.
Prior to joining AZ, Diane was Vice President, Specialty Care Payer & Channel Group at Pfizer, where she gained her expertise in specialty leading the strategy for business to business customers for six brand franchises and eleven brands. While at Pfizer, she was selected as a Board Member of National Association of Specialty Pharmacy (NASP). Before the acquisition by Pfizer, she was Vice President of Health Systems Marketing at Wyeth and led an integrated strategic plan for the top 20 customers and full portfolio of brands which resulted in the formation of a Payer Center of Excellence.
Prior to joining Wyeth, Diane was Executive Director, Worldwide Business Development and Strategy at GlaxoSmithKline (GSK) in the Consumer Healthcare Business. Over 12 years, she held leadership roles in managed care, brand marketing, new product development, acquisition integration, licensing, strategy and marketing capability development. She was also selected as the 2003 Rising Star by the Healthcare Businesswoman’s Association.
Diane began her career at IBM and in her last role, led IBM’s launch and entry into the Health Data Networking business through a joint venture with one of IBM’s largest customers. She graduated from both IBM’s intensive two-year marketing and account management training program and IBM’s customized version of an MBA, completing it while working full-time.
Diane holds a Bachelor’s degree from Dickinson College and spent her junior year in Nantes, France. She is an active Board member and advisor to: National Association of Specialty Pharmacy, Professional Women’s Roundtable, United Way Women’s Initiative, Leadership Philadelphia and the Support Center for Child Advocates.